Colton Thomas

Charged Alpha Stock Encyclopedia

Business EN ↓ 1765 episodi

Charged Alpha reviews earnings for each stock in the Russel 1000 every quarter. Each podcast gives thorough analysis, along with an in-depth profile in the beginning of the episode of the company, what they do, how they earn money and what to look for.

Visita il sito del podcast e sostieni chi lo crea: chargedalpha.podbean.com

Autore

Colton Thomas

Categoria

Business

Sito del podcast

chargedalpha.podbean.com

Ultimo episodio

28 ott 2026

Dove ascoltare?

I podcast nell'app Replaio Radio In arrivo

I podcast stanno per arrivare nell'app. Installala ora e scopri per primo un modo tutto nuovo di vivere i podcast

Scaricala su Google Play Installala gratis Android quasi 10 mln di download · valutazione 4,8 iOS in arrivo

Episodi

NRG Energy (NRG): Stock CRASHES 15% On REAFFIRMED Guidance — Is NRG Stock a Buy Now? 04.08.2026

NRG Energy, Inc. (NRG) Q2 2026 — Reported Aug 4, 2026 pre-open, quarter ended June 30, 2026. Revenue $7,481M (+11%) beat ~$7,312M est. ADJUSTED EPS $1.49 MISSED ~$1.69; GAAP EPS $2.32. Adj EBITDA $1,217M (+34%). FY26 guidance REAFFIRMED. Stock -15.4% to $117.13, a 52-week low. NRG beat on revenue, grew adjusted EBITDA 34%, reaffirmed full-year guidance and announced a 1.2 GW gas plant for an AI hy...

Zebra (ZBRA): Stock EXPLODES 23% — But 80% Of The Raise Is Old News. Is ZBRA Stock a Buy? 04.08.2026

Zebra Technologies Corporation (ZBRA) Q2 2026 — Reported Aug 4, 2026 pre-open for the quarter ENDED JULY 4, 2026. Net sales $1,557M, +20.4% (organic +9.2%). GAAP EPS $4.85; NON-GAAP EPS $6.35 vs ~$4.36 est. FY26 guide raised to $20.75-$21.25. Stock +22.7% to $357.85. Zebra beat by almost two dollars and raised full-year guidance by $2.50 - and the stock ripped 22.7%. But $2.00 of that raise is jus...

BioNTech (BNTX): 80% Of This Company Is Cash. Guidance Cut, Stock UP. Is BNTX Stock a Buy? 04.08.2026

BioNTech SE (BNTX) Q2 2026 — Reported Aug 4, 2026 pre-open for the three and six months ended June 30, 2026. Revenue EUR 105.6M, DOWN 59.5%. Net loss EUR 820.8M, more than DOUBLE the EUR 386.6M a year ago. FY2026 revenue guidance CUT from EUR 2.0-2.3B to EUR 1.6-1.9B. The ADR opened at $89.18, fell to $88.20, then reversed to $93.245 (+1.1%). ADS ratio 1:1; EUR/USD 1.1526. BioNTech cut 2026 revenu...

Cummins (CMI): Record Quarter, Raised Guidance - And The Stock Fell 5.5%. Is CMI Stock a Buy? 04.08.2026

Cummins Inc. (CMI) Q2 2026 — Reported Aug 4, 2026 pre-open for the quarter ended June 30, 2026. Revenue $9,457M, +9.4%, a Q2 record, BEATING the $9.31B consensus. Diluted EPS $6.73 vs $7.17 expected - a 6.1% MISS, the first in five quarters. EBITDA $1,653M, 17.5% of sales, DOWN from 18.4%. FY2026 revenue guidance RAISED to +10-13% from +8-11%. Prior close $648.85; the stock sat at $613.26 (-5.5%)...

Spotify (SPOT): 300 Million Subscribers - And Ad Revenue Grew 1%. Is SPOT Stock a Buy? 04.08.2026

Spotify Technology S.A. (SPOT) Q2 2026 — Reported Aug 4, 2026 pre-open for the quarter ended June 30, 2026. Spotify REPORTS IN EUROS and TRADES IN DOLLARS, so every figure is labelled. Revenue EUR4,777M, +14% (+15% cc), in line with guide. Gross margin 33.4%, an all-time record. Operating income EUR655M vs a EUR630M guide - EUR655M, NOT the EUR762M some headlines used, which is the USD conversion....

Entegris (ENTG): The Secular Half Grew 4.6%, The Cyclical Half Grew 17%. Is ENTG Stock a Buy? 04.08.2026

Entegris, Inc. (ENTG) Q2 2026 — Reported August 4, 2026 BEFORE the US open for the fiscal second quarter ENDED JUNE 27, 2026 (a 13-week quarter - not June 30). Revenue $883.2M, +11.5% YoY and +8.8% sequential, beating the ~$835.8M FactSet consensus by $47.4M or 5.7%. Non-GAAP diluted EPS $0.93 vs $0.66 (+40.9%); GAAP EPS $0.61 vs $0.35 (+74.3%). GAAP gross margin 47.6% (+320bps), GAAP operating ma...

IDEXX (IDXX): Vet Visits Are Falling, It Grew 11 Points Faster. Is IDXX Stock a Buy? 04.08.2026

IDEXX Laboratories, Inc. (IDXX) Q2 2026 — Reported August 4, 2026 BEFORE the US open for Q2 2026 (the quarter ended June 30, 2026). Revenue $1,216.6M, +9.7% reported and +9.0% organic, vs a ~$1.20B consensus. Diluted EPS $4.27, +17.6%, vs a $3.96 consensus - but $0.14 of that came from share-based-compensation tax benefits and $0.06 from currency. Gross margin 64.0% (+140bps reported, +120bps comp...

Ultra Clean (UCTT): Beat by $57M, Burned $100M of Cash. Is UCTT Stock a Buy? 04.08.2026

Ultra Clean Holdings, Inc. (UCTT) Q2 2026 — Reported August 3, 2026 after the US close for Q2 2026 (the quarter ended June 26, 2026). Revenue $644.9M (+24.3% YoY, +20.8% QoQ) vs a $587.6M consensus and the company's own $565-605M guidance - a beat above the TOP END. Products $572.7M (+25.9%), Services $72.2M (+13.0%). GAAP gross margin 16.1%, operating margin 4.6%, net income attributable to UCT $...

Grab (GRAB): EBITDA +54%, Profit 12x - But Free Cash Flow FELL. Is GRAB a Buy? 04.08.2026

Grab Holdings Limited (GRAB) Q2 2026 — Reported August 3, 2026 after the US close for Q2 2026 (the quarter ended June 30, 2026). Revenue $997M (+22% YoY, +21% constant currency) vs ~$990.4M expected. Adjusted EBITDA $168M (+54%), margin 16.9% from 13.3% - an 18th consecutive quarter of adjusted EBITDA growth. EPS $0.06 vs a $0.01 consensus. Profit for the period $235M vs $20M. On-demand GMV $6.5B...

ON Semiconductor (ON): EPS +40%, Free Cash Flow 4x, Stock -40%. Is ON a Buy? 04.08.2026

ON Semiconductor Corporation (onsemi) (ON) Q2 2026 — Reported August 3, 2026 before the open for Q2 2026 (the quarter ended July 3, 2026). Revenue $1,603.5M (+9.2% YoY, +6.0% QoQ) vs ~$1.59B expected. Non-GAAP EPS $0.74 (+39.6%) vs ~$0.715 expected; GAAP EPS $0.56. Non-GAAP gross margin 39.3% (+170bps), non-GAAP operating margin 20.8%. Free cash flow $425.4M, quadruple last year's $106.1M. $332M o...

JAZZ (Jazz Pharmaceuticals): The EPS ’Miss’ Was a $77M Check It Won’t Add Back — Q2 2026 04.08.2026

Jazz Pharmaceuticals plc (JAZZ) Q2 2026 — Reported after the close on August 3 (three months ended June 30, 2026). Total revenue $1,208.3M, +15.6%, a company record and ~$94M above consensus. GAAP gross margin 90.4%. GAAP diluted EPS $2.78 (from -$11.74). Non-GAAP adjusted EPS $5.71 vs $6.18 expected — but the entire shortfall is $77.0M of acquired IPR&D ($0.94/share after tax) that Jazz, unli...

POWL (Powell Industries): A Record $934M Order Book — And 57% Of It Was Three Orders. Q3 FY2026 04.08.2026

Powell Industries, Inc. (POWL) Q3 FY2026 — Reported after the close on August 3 (the 8-K hit EDGAR at 4:28pm ET; fiscal Q3 2026, the three months ended June 30, 2026). Revenue $311.7M, +8.9%. Diluted EPS $1.42 vs $1.32. New orders a record $934M, +158%, a 3.0x book-to-bill. Backlog $2.4B, +69% y/y and +35% sequentially. Cash and short-term investments $633.6M with no debt. The stock closed at $219...

FANG (Diamondback): Record $6.65 EPS — And The Gas Sold For MINUS $2.15. Q2 2026 04.08.2026

Diamondback Energy, Inc. (FANG) Q2 2026 — Reported after the close on August 3 (three months ended June 30, 2026). Total revenue $5,562M, +51.2%. GAAP diluted EPS $6.65 vs $2.38 a year ago; adjusted EPS $6.48 vs a ~$6.40 consensus. Free cash flow $2,330M on capex of $996M. Production crossed 1,018 MBOE/d — above one million barrels of oil equivalent per day for the first time in company history —...

AEIS (Advanced Energy): The AI Power Beat That Wasn’t AI — 93% Came From Semi-Cap. Q2 2026 04.08.2026

Advanced Energy Industries, Inc. (AEIS) Q2 2026 — Reported after the close on August 3 (three months ended June 30, 2026). Revenue $574.1M, +30.1%, above the HIGH END of guidance. GAAP gross margin 41.1% vs 37.0%. GAAP EPS from continuing operations $1.29; non-GAAP EPS $2.74 vs $2.21 expected. Q3 guidance $640M +/- $20M and non-GAAP EPS $3.00 +/- $0.25 vs consensus of ~$576M and $2.46 — the raise...

TKO (UFC + WWE): A Beat, A Raise — And 66% Of The Profit Isn’t Yours. Q2 2026 04.08.2026

TKO Group Holdings, Inc. (TKO) Q2 2026 — Reported after the close on August 3 (three months ended June 30, 2026). Revenue $1,547.1M, +18.3%. Adjusted EBITDA $649.9M, +23.4%, margin 42% vs 40%. GAAP diluted EPS $1.34 vs $1.41 expected — a seven-cent miss. FY2026 guidance RAISED again, to $5.775-5.825B revenue and $2.275-2.305B EBITDA. UFC $535.7M (+28.8%), WWE $620.9M (+11.6%), IMG $354.7M (+15.7%)...

VRTX (Vertex Pharmaceuticals): A Beat, A Raise — And 75% Of Revenue Just Shrank. Q2 2026 04.08.2026

Vertex Pharmaceuticals Incorporated (VRTX) Q2 2026 — Reported after the close on August 3 (three months ended June 30, 2026). Total revenue $3,333.9M, +12.5%, ahead of the ~$3.23B expected. GAAP EPS $4.31 vs $3.99; non-GAAP EPS $4.73 vs the $4.74 expected — a one-cent miss. FY2026 revenue guidance RAISED to $13.1-13.2B from $12.95-13.1B, with every expense line left unchanged. CASGEVY $76.4M, +151...

BWXT (BWX Technologies): Record Backlog, Guidance Raised — And 67% Of Revenue Grew 2%. Q2 2026 04.08.2026

BWX Technologies, Inc. (BWXT) Q2 2026 — Reported after the close on August 3 (three months ended June 30, 2026). Revenue $901.6M, +18.0%. GAAP EPS $0.97 vs $0.85; non-GAAP EPS $1.07 vs $1.02, ahead of the ~$1.04 expected. Adjusted EBITDA $155.5M, +6.6%. Record backlog $8.40B, +39.6%. Guidance raised four ways. BWXT also agreed to sell its medical business to Nordic Capital for up to $800M and clos...

Sterling (STRL): Record Quarter, Guidance Raised — And 78% Of Revenue Is Now One Bet. Q2 2026 04.08.2026

Sterling Infrastructure, Inc. (STRL) Q2 2026 — Reported after the close on August 3 (the three months ended June 30, 2026). Revenue $1,168.2M, up 90.1% from $614.5M with roughly 50 points organic. GAAP diluted EPS $5.00 vs $2.31, +116%. Adjusted diluted EPS $5.80 vs $2.69. Adjusted EBITDA $256.7M at a record 22.0% margin. Signed backlog $4.33B, +116% and +50% organic. Full-year guidance raised for...

Palantir (PLTR): Revenue Grew 93% — Bookings Grew 49%. Is PLTR a Buy After Q2 2026? 04.08.2026

Palantir Technologies Inc. (PLTR) Q2 2026 — Reported after the close on August 3 (the three months ended June 30, 2026). Revenue $1,935.5M, up 92.8% from $1,003.7M against a Street number near $1,810M — growth ACCELERATED from 48%. GAAP diluted EPS $0.41 vs $0.13. GAAP operating margin 47.1% from 26.8%; adjusted 62%. Rule of 40 score 155%, from 94%. Adjusted free cash flow $1,220.4M at 63%. Every...

Old Dominion (ODFL): Record Operating Ratio — 91% Of The Growth Was Diesel. Is ODFL a Buy? 04.08.2026

Old Dominion Freight Line, Inc. (ODFL) Q2 2026 — Reported before the open on July 29 (Q2 2026, the three months ended June 30, 2026). Revenue $1,554.0M, up 10.4% from $1,407.7M, against a Street number near $1,539.4M. Diluted EPS $1.68 against $1.27, up 32.3%, and against a $1.54 estimate — a figure management says ties the company record set in Q3 2022. The operating ratio improved 450 basis poin...

O’Reilly (ORLY): A 6% Comp — And The Operating Margin FELL. Is ORLY a Buy? 04.08.2026

O'Reilly Automotive, Inc. (ORLY) Q2 2026 — Reported after the close on July 29 (Q2 2026, the three months ended June 30, 2026). Sales $4,892.0M, up 8.1% from $4,525.1M. Comparable store sales +6.0%, on top of +4.1% a year ago. Diluted EPS $0.86 against $0.78, up 10.3%, and against a Street number near $0.86 — in line. Management RAISED full-year comparable sales guidance to 4.0-6.0% from 3.0-5.0%...

Royal Caribbean (RCL): Revenue +6.5%, Earnings DOWN. Is RCL a Buy? 04.08.2026

Royal Caribbean Cruises Ltd. (RCL) Q2 2026 — Reported before the open on July 28 (Q2 2026, the three months ended June 30, 2026). Total revenue $4,832M, up 6.5% from $4,538M. Adjusted EPS $4.21 against a Street number near $3.98 — a beat — and against $4.38 in the same quarter last year, a 3.9% DECLINE. Operating income fell 1.7% to $1,307M and the operating margin went from 29.3% to 27.0%. Adjust...

MakeMyTrip (MMYT): Bookings +19.9%, Profit -65%. Is MMYT a Buy? 04.08.2026

MakeMyTrip Limited (MMYT) Q1 FY2027 — Reported August 3 (Q1 FY2027, the three months ended June 30, 2026 — MakeMyTrip's fiscal year ends 31 March, so the June quarter is Q1 of FY2027). Gross bookings $2,854.7M, up 9.4% reported and 19.9% in constant currency. Revenue $285.6M, up 6.2% reported and 16.1% in constant currency. Adjusted operating profit $51.4M, up 8.6%. But profit for the period fell...

EchoStar (ECHO): $24.12 EPS Came From A Bankruptcy. Is ECHO a Buy? 03.08.2026

EchoStar Corporation (ECHO) Q2 2026 — Reported August 3 (Q2 2026, the three months ended June 30, 2026). Total revenue $3.576B, DOWN 4.0% from $3.725B. Diluted EPS $24.12 and net income to EchoStar of $8.462B — but $9.729B of the $9.790B of pre-tax income is a NON-CASH deconsolidation gain booked when DISH DBS and DISH Wireless filed prepackaged Chapter 11 on June 30. Strip it out and pre-tax inco...

TG Therapeutics (TGTX): Revenue +70% And Operating Income FELL. Is TGTX a Buy? 03.08.2026

TG Therapeutics, Inc. (TGTX) Q2 2026 — Reported before the open (Q2 2026, the three months ended June 30, 2026). Total revenue $240.3M, +70.3% — a ~$10.6M BEAT. BRIUMVI U.S. net product revenue $227.7M, +64%. But diluted EPS was $0.05 against a Street estimate near $0.31, and operating income FELL to $21.7M from $34.8M — a 9.0% margin against 24.7%. FY2026 total revenue target RAISED to ~$950M fro...

Ascolta il podcast Charged Alpha Stock Encyclopedia su Replaio

Radio e podcast in un'unica app - gratis e senza registrazione. Installala oggi e non perderti il lancio

Scaricala su Google Play

Replaio non è un editore di podcast; i nomi dei programmi, le copertine e l'audio appartengono ai rispettivi autori e vengono distribuiti tramite feed RSS pubblici